Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease.

Reith R SarkarSunil H PatelJ Kellogg ParsonsRishi DekaAbhishek KumarJohn P EinckArno J MundtA Karim KaderChristopher J KanePaul J RiviereRana McKayJames D MurphyBrent S Rose

Published in: Prostate cancer and prostatic diseases (2020)

In this multi-ethnic national cohort, TT did not increase the risks of biochemical recurrence or prostate cancer-specific or overall mortality after surgery or radiation. These data suggest that TT is safe in appropriate men after definitive treatment of localized prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
cardiovascular disease
stem cells
radiation therapy
human health
type diabetes
risk assessment
climate change
big data
free survival
radiation induced
bone marrow
artificial intelligence
cell therapy
smoking cessation